Medical network - on January 3, Shanghai will be 24 drugs into the reimbursement list, these varieties in the nation's drug price negotiations drugs and some tumor molecular targeted drugs list (see attachment). Since January 1, 2017.
This part of the medicine practice "hospitals, doctors, or indications" of "armed" management. The medical establishment that decide a dot must be equipped with the management of clinical pharmacists team involved in medication; To use tumor molecular targeted drugs, have limited to malignant tumor treatment (chemotherapy, radiation therapy, isotope therapy, interventional therapy, Chinese medicine therapy) health registration of a serious illness, and in principle should have genetic testing ability of medical institutions.
The doctors prescribe tumor molecular targeted drugs must be related to clinical departments are above the physician, be determined by the medical establishment that decide a dot after the specific list submitted to the municipal medical insurance business management center for the record.
Employee basic medical insurance, medical insurance ginseng protect personnel to the clinic use of drugs in small towns tumor molecular targeted drugs incorporated in the outpatient service a serious illness "registration", limited to malignant tumor treatment (chemotherapy, radiation therapy, isotope, interventional therapy, Chinese medicine treatment) to register the same medical establishment that decide a dot of a serious illness.
Part of centralized purchasing of drugs work by the municipal management is responsible for the drug centralized bid procurement affairs, determine the purchase prices for medicare agreement purchase price, through medicine centralized purchasing service and supervision information system (i.e., "sunshine platform") unified push to the medical establishment that decide a dot.
Attachment:
|
